Clik here to view.
Dongguk University Ilsan Hospital Completes First Brain Tumor Treatments with...
GOYANG-SI, South Korea ZAP Surgical Systems, Inc., a global leader in surgical robotics, proudly announces the completion of first patient treatments at Dongguk University Ilsan Hospital using the...
View ArticleClik here to view.
S.BIOMEDICS Dopamine Cell Therapy for Parkinson’s Disease with TED-A9 Shows...
SEOUL, South Korea S.BIOMEDICS (KOSDAQ: 304360) announced positive one-year assessment data from the first 3 participants (first low dose cohort) of Phase I/IIa clinical trial for Parkinson’s...
View ArticleClik here to view.
MMI签订多个分销协议并获得监管机构批准为全球扩张注入动力
佛罗里达州杰克逊维尔 (美国商业资讯)– MMI（Medical Microinstruments, Inc.）是一家机器人技术公司，致力于为病情复杂的患者提供更多治疗选择并改善临床疗效。今天该公司宣布了跨越两大洲的里程碑进展，进一步扩大了Symani®手术系统的全球覆盖范围。该公司宣布： 与日本领先的医疗设备开发商和制造商Gunze Medical...
View ArticleClik here to view.
MMI Builds Global Momentum with Multiple Distribution Agreements and...
JACKSONVILLE, Fla. MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today...
View ArticleClik here to view.
MMI、複数の販売契約と規制承認でグローバル展開に弾みをつける
フロリダ州、ジャクソンビル （ビジネスワイヤ） — 複雑な病状を抱える患者の治療選択肢を増やし、臨床転帰の改善に取り組むロボティクス企業のMMI（Medical Microinstruments, Inc.）は、Symani® Surgical Systemのグローバル展開拡大に向けた二大陸にわたるマイルストーンを発表しました。発表内容は以下の通りです。...
View ArticleClik here to view.
MicroVention宣布与前员工就商业秘密盗用和违约等索赔达成和解
加利福尼亚州，亚里索维耶荷 (美国商业资讯)– Terumo Corporation的全资子公司MicroVention今天宣布，美国加利福尼亚州中区地方法院已发布禁令，永久禁止被告David Ferrera、Nguyen (“Jake”) Le和Michelle Tran（MicroVention的前雇员，以下称为...
View ArticleClik here to view.
Propanc Biopharma’s CSO Predicts PRP Could Solve Problem That Impacts...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Samsara Vision Announces First SING IMT® (Smaller-Incision New-Generation...
FAR HILLS, N.J. Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD) through advanced visual prosthetic devices,...
View ArticleClik here to view.
ラピッド・メディカル™、アクティブ・アクセス・ソリューションのFDA認可を受け米国初の神経血管手術を実施
イスラエル、ヨクネアム&コロラド州コロラド・スプリングス （ビジネスワイヤ） — 高度な血管治療機器の開発をけん引するRapid...
View ArticleClik here to view.
Rapid Medical™的主动进入解决方案获得美国FDA批准并在美完成首次神经血管病例治疗
以色列约克南和科罗拉多州科罗拉多泉城 (美国商业资讯)– 先进血管内设备领先开发商Rapid Medical™在2024年神经介入手术学会（SNIS）第21届年会上宣布在美国首次使用突破性可偏转进入平台DRIVEWIRE 24进行了手术。DRIVEWIRE采用主动技术，可连接各种导管，直接进入血管内位置。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
BCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s...
WASHINGTON Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also...
View ArticleClik here to view.
Fast Company Magazine Awards Xenco Medical with 2024 Innovation by Design...
SAN DIEGO Fast Company Magazine has awarded pioneering life sciences company Xenco Medical with its prestigious 2024 Innovation by Design Award for its groundbreaking TrabeculeX Continuum, the first...
View ArticleClik here to view.
Japanese Medtech Startup, CoreTissue BioEngineering, Becomes First Company...
YOKOHAMA, Japan CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company to be accepted by...
View ArticleClik here to view.
SanBio Obtains Marketing Approval for “AKUUGO® Suspension for Intracranial...
TOKYO SanBio Co., Ltd. (TOKYO:4592) (head office: Tokyo, representative director & CEO: Keita Mori) hereby announces that today on July 31 2024, it obtained conditional and time-limited...
View ArticleClik here to view.
IMS Shin-Matsudo Central General Hospital Completes First Patient Treatment...
SHINMATSUDO, Japan ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that IMS Shin-Matsudo Central General Hospital, located in the heart of...
View ArticleClik here to view.
Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer;...
TOKYO Nichi BRITE Beta glucan administration resulted in enhancement of immunity followed by reduction in biomarkers of pancreatic cancer and that of its recurrence in patients undergoing surgical...
View ArticleClik here to view.
Nichi BRITE β-葡聚糖作为辅助胰腺癌治疗的营养补充剂；日本近森医院报告了令人鼓舞的临床结果
东京 (美国商业资讯)– 服用Nichi BRITE β-葡聚糖可提高免疫力，进而降低接受恶性胰腺肿瘤手术切除患者的胰腺癌生物标志物及其复发率，这一发现在日本横滨举行的ASCO® Breakthrough会议上进行了呈报。在胃肠外科医生和日本高知县近森医院营养支持小组的研究中，与对照组相比，给药Nichi...
View ArticleClik here to view.
Clik here to view.
HistoSonics宣布获得超额认购的1.02亿美元D轮融资，以推进非侵入性组织摧毁术平台的推出
明尼阿波利斯 (美国商业资讯)– HistoSonics是Edison®组织摧毁术系统和新型组织摧毁术疗法平台的制造商。该公司今天宣布完成超额认购的1.02亿美元D轮融资。本轮融资由全球领先的成长期投资机构Alpha Wave Ventures领投，新投资者Amzak Health和HealthQuest Capital以及现有投资者Johnson & Johnson...
View ArticleClik here to view.
ヒストソニックス、非侵襲的なヒストトリプシー・プラットフォームの立ち上げ拡大に向けた1億200万ドルのシリーズD資金調達を発表
ミネアポリス （ビジネスワイヤ） — ヒストソニックスは、Edison®ヒストトリプシーシステムのメーカーであり、画期的なヒストトリプシー療法のプラットフォームです。このたびヒストソニックスは、1億200万ドルのシリーズD資金調達を完了したことを発表しました。本ラウンドは、成長段階の投資で世界をリードするアルファ・ウェーブ・ベンチャーズによって主導されており、新規投資家であるAmzak...
View Article